Jeff Yass’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
Other funds holding URGN
KCM
ACA
OM
Jeff Yass's URGN Position: Q3 2026 in Review
Jeff Yass increased its UroGen Pharma (URGN) stake by 1,475% in Q3 2026, buying an estimated $4.29M and bringing the position to 106,837 shares worth $4.34M. The position accounts for ﹤0.01% of the portfolio, ranked #4699.
Jeff Yass first reported a position in URGN in Q3 2018 and has held it in 25 quarters since. The position peaked at $6.64M in Q2 2025. 217 funds tracked by Wall St. Rank hold URGN as of Q3 2026.
- Jeff Yass held 106,837 shares of UroGen Pharma worth $4.34M as of Q3 2026.
- Jeff Yass bought 100,055 UroGen Pharma shares in Q3 2026, an estimated $4.29M.
- UroGen Pharma made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #4699 holding.
- Jeff Yass first reported a position in UroGen Pharma in Q3 2018 and has held it in 25 quarters since.
- Jeff Yass's UroGen Pharma position peaked at $6.64M in Q2 2025.
- 217 funds tracked by Wall St. Rank held UroGen Pharma as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.